Document Detail


Is there a pre-RC checkpoint that cancer cells lack?
MedLine Citation:
PMID:  16880740     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Critical for genomic integrity, accurate DNA replication is tightly regulated by the convergence of prereplication protein complexes (pre-RCs) to "license" replicating origins on DNA in G(1) and is activated by S-phase promoting kinases that selectively target and trigger origin firing in S-phase. To present, a checkpoint mechanism monitoring pre-RC complex formation and activation has yet to be elucidated. However, perturbation of these protein complexes has yielded divergent phenotypes in recent reports: normal cells arrest in the cell cycle, whereas cancerous cells arrest and die. These data implicate a mechanism by which normal cells sense pre-RC deficiency and then signal for cell cycle arrest. The potential for therapeutic exploits of this disparity between normal and cancer cells is apparent. Here, we explore recent data supporting the existence of a pre-RC checkpoint that ensures faithful pre-RC formation, a cell cycle mechanism that is intriguingly compromised in cancer cells.
Authors:
Eric Lau; Wei Jiang
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2006-08-01
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  5     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-24     Completed Date:  2007-01-03     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1602-6     Citation Subset:  IM    
Affiliation:
The Burnham Institute for Medical Research, La Jolla, California 92037, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
DNA Replication / physiology*
Humans
Models, Biological*
Neoplasms / genetics,  pathology*,  therapy
Grant Support
ID/Acronym/Agency:
2T32 CA77109-06A2/CA/NCI NIH HHS; CA97950/CA/NCI NIH HHS; GM67859/GM/NIGMS NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cdk1/cyclin B-mediated phosphorylation stabilizes SREBP1 during mitosis.
Next Document:  Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site f...